Clinical trial Recruiting at 1 site Interventional Ages 18 to 42 Women only

Automated AI ranking of embryos with iDAScore

Official title: PROSPECTIVE EVALUATION OF THE IDASCORE ALGORITHM FOR EMBRYO RANKING

Run by Universitair Ziekenhuis Brussel · NCT07187934 · Data updated 2026-11-12

This will test whether an automated AI tool called iDAScore can rank frozen embryos as well as an embryologist for IVF patients using a freeze-all approach.

More Pregnancy trials

Quick facts

Study typeInterventional
Ages18 Years to 42 Years
SexWomen only
Enrollment1325 (estimated)
SponsorUniversitair Ziekenhuis Brussel
Academic / other
Locations1 site (Brussels, Brussels Capital)
StatusRecruiting
StartedDecember 11, 2025
Main results expectedDecember 11, 2028
Study endsOctober 1, 2029
Registry record updatedDecember 23, 2025
Trial IDNCT07187934 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are IVF/ICSI patients aged 18–42 with BMI 18–35 planned for a day-5 freeze-all approach who produce at least two blastocysts that meet cryopreservation criteria.

Probably not a fit

Patients ineligible for the protocol—such as those using preimplantation genetic testing, frozen oocytes, in vitro maturation cycles, with proven untreated intra-uterine pathologies or endometriosis stage 3–4, or those treated outside the Brussels site—would not be expected to benefit from this intervention.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

IVF/ICSI patients planned for a freeze-all protocol who produce at least two vitrifiable blastocysts are randomized to embryo ranking by an embryologist or by the iDAScore AI. Embryos are cultured in an EmbryoScope+ time-lapse incubator, vitrified on day 5 (or day 6 if needed), and then warmed and transferred one by one in frozen embryo transfer cycles according to their assigned rank. The control group uses manual ranking based on Gardner criteria and full morphokinetics, while the study group uses the iDAScore to order embryos. The primary outcome is transfer-to-pregnancy, measured as the average number of transfers needed to achieve a clinical pregnancy.

Why it matters

Potential benefit: If successful, this approach could standardize embryo selection, reduce variability between embryologists, and decrease the number of transfer cycles needed to achieve pregnancy.

How similar studies have gone: Retrospective studies and pilot reports of AI embryo-ranking tools, including iDAScore, have shown promising correlations with implantation but prospective randomized evidence is still limited.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* patients undergoing an ICSI/IVF treatment (with donor or own oocytes) that are planned for a 'freeze-all' strategy on day 5
* all types of sperm samples (ejaculated or testicular, fresh or frozen, partner or donor origin)
* Minimum 8 follicles (≥ 12 mm) on last follicular measurement before oocyte retrieval
* 18 ≤ Age ≤ 42 years
* 18 ≤ BMI ≤ 35 kg/m²
* Maximum third IVF/ICSI cycle
* Participants can be included only once in the trial

Exclusion Criteria:

* Embassy patients
* Use of frozen oocytes
* In vitro maturation (IVM) cycles
* Pre-implantation genetic Testing (PGT) cycles
* Proven untreated intra-uterine pathologies (e.g. Asherman syndrome, adenomysosis)
* Endometriosis stage 3/4

Where it's running

  • Brussels IVF, UZ Brussel
    Brussels, Brussels Capital, Belgium
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.